Titan Pharma (TTNP) Misses Q4 EPS by 31c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St subdued as markets pause after S&P record high; data, Mideast in focus
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Titan Pharmaceuticals Reports Fourth Quarter And Full Year 2018 Financial Results
April 1, 2019 4:30 PM EDTSOUTH SAN FRANCISCO, Calif., April 1, 2019 /PRNewswire/ --Â Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) today reported financial results for the fourth quarter and full year ended December 31, 2018 and provided an update on its business.
Full Year 2018 Business Highlights
In February 2018, Titan entered into an... More